Analysis of cross neutralizing activity of antibodies from sera of severe fever with thrombocytopenia syndrome patients to deal with different genotype strains

BackgroundSevere fever with thrombocytopenia syndrome bunyavirus (SFTSV) is a tick-borne virus that causes severe communicable fever with thrombocytopenia syndrome (SFTS) with an average case fatality rate of 10%. In the study, we aimed to identify the cross-neutralizing antibody (nAb) against diffe...

Full description

Bibliographic Details
Main Authors: Jiaxin Xu, Yuanni Liu, Fan Zhang, Xin Wang, Weijin Huang, Yulong Wu, Boqing Li, Jiapeng Zhuang, Yixing Bing, Youchun Wang, Yuanyuan Qiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.1020545/full
_version_ 1817978846291427328
author Jiaxin Xu
Yuanni Liu
Fan Zhang
Xin Wang
Weijin Huang
Yulong Wu
Boqing Li
Jiapeng Zhuang
Yixing Bing
Youchun Wang
Yuanyuan Qiao
author_facet Jiaxin Xu
Yuanni Liu
Fan Zhang
Xin Wang
Weijin Huang
Yulong Wu
Boqing Li
Jiapeng Zhuang
Yixing Bing
Youchun Wang
Yuanyuan Qiao
author_sort Jiaxin Xu
collection DOAJ
description BackgroundSevere fever with thrombocytopenia syndrome bunyavirus (SFTSV) is a tick-borne virus that causes severe communicable fever with thrombocytopenia syndrome (SFTS) with an average case fatality rate of 10%. In the study, we aimed to identify the cross-neutralizing antibody (nAb) against different genotype strains from sera of SFTSV infected patients.MethodsFirstly the genotype of SFTSV was identified by constructing a phylogenetic tree based on the M segments epidemic in the Jiaodong area of Shandong province, then different sera of subjects cross reactive with recombinant Gn (rGn-Fc) or recombinant Gc (rGc-Fc) of 0921 strain were examined. The levels of polyclonal nAbs from sera of 25 convalescents were measured by a pseudovirus-based neutralizing experiment.ResultsWe found local endemic strains were mainly C2 and C3 isolates of SFTSV. 14 of 15 sera from donors reacted with 0921 rGn-Fc, and 9 of 15 sera from donors reacted with 0921 rGc-Fc. Cross nAbs were produced by 10 of 25 sera from donors during the period of 2019–2021. Among these, five nAbs (A2, A4, A5, L9, and L10) neutralized the pseudoviruses of HB29, Gangwon, HN13, HN20, SPL030A, and SD4 strains.ConclusionOur data suggested that epidemic strains showed relatively stable heredity. Some blood sources from patients produced cross nAbs that could neutralize all of the strains examined. These findings highlight the important role played by humoral immunity in combatting SFTSV.
first_indexed 2024-04-13T22:35:34Z
format Article
id doaj.art-b345eb6565844bf6886022a98b0c1fa9
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-13T22:35:34Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-b345eb6565844bf6886022a98b0c1fa92022-12-22T02:26:47ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2022-10-011310.3389/fmicb.2022.10205451020545Analysis of cross neutralizing activity of antibodies from sera of severe fever with thrombocytopenia syndrome patients to deal with different genotype strainsJiaxin Xu0Yuanni Liu1Fan Zhang2Xin Wang3Weijin Huang4Yulong Wu5Boqing Li6Jiapeng Zhuang7Yixing Bing8Youchun Wang9Yuanyuan Qiao10Department of Pathogenic Biology, Binzhou Medical University, Yantai, ChinaDepartment of Infectious Diseases and Clinical Laboratory, Yantai Qishan Hospital, Yantai, ChinaDepartment of Pathogenic Biology, Binzhou Medical University, Yantai, ChinaDepartment of Infectious Diseases and Clinical Laboratory, Yantai Qishan Hospital, Yantai, ChinaKey Laboratory for Quality Research and Evaluation of Biological Products, National Medical Products Administration, Beijing, ChinaDepartment of Pathogenic Biology, Binzhou Medical University, Yantai, ChinaDepartment of Pathogenic Biology, Binzhou Medical University, Yantai, ChinaDepartment of Pathogenic Biology, Binzhou Medical University, Yantai, ChinaDepartment of Pathogenic Biology, Binzhou Medical University, Yantai, ChinaKey Laboratory for Quality Research and Evaluation of Biological Products, National Medical Products Administration, Beijing, ChinaDepartment of Pathogenic Biology, Binzhou Medical University, Yantai, ChinaBackgroundSevere fever with thrombocytopenia syndrome bunyavirus (SFTSV) is a tick-borne virus that causes severe communicable fever with thrombocytopenia syndrome (SFTS) with an average case fatality rate of 10%. In the study, we aimed to identify the cross-neutralizing antibody (nAb) against different genotype strains from sera of SFTSV infected patients.MethodsFirstly the genotype of SFTSV was identified by constructing a phylogenetic tree based on the M segments epidemic in the Jiaodong area of Shandong province, then different sera of subjects cross reactive with recombinant Gn (rGn-Fc) or recombinant Gc (rGc-Fc) of 0921 strain were examined. The levels of polyclonal nAbs from sera of 25 convalescents were measured by a pseudovirus-based neutralizing experiment.ResultsWe found local endemic strains were mainly C2 and C3 isolates of SFTSV. 14 of 15 sera from donors reacted with 0921 rGn-Fc, and 9 of 15 sera from donors reacted with 0921 rGc-Fc. Cross nAbs were produced by 10 of 25 sera from donors during the period of 2019–2021. Among these, five nAbs (A2, A4, A5, L9, and L10) neutralized the pseudoviruses of HB29, Gangwon, HN13, HN20, SPL030A, and SD4 strains.ConclusionOur data suggested that epidemic strains showed relatively stable heredity. Some blood sources from patients produced cross nAbs that could neutralize all of the strains examined. These findings highlight the important role played by humoral immunity in combatting SFTSV.https://www.frontiersin.org/articles/10.3389/fmicb.2022.1020545/fullsevere fever with thrombocytopenia syndrome bunyavirushumoral immunityneutralizing antibodyglycoproteinphylogenetic tree
spellingShingle Jiaxin Xu
Yuanni Liu
Fan Zhang
Xin Wang
Weijin Huang
Yulong Wu
Boqing Li
Jiapeng Zhuang
Yixing Bing
Youchun Wang
Yuanyuan Qiao
Analysis of cross neutralizing activity of antibodies from sera of severe fever with thrombocytopenia syndrome patients to deal with different genotype strains
Frontiers in Microbiology
severe fever with thrombocytopenia syndrome bunyavirus
humoral immunity
neutralizing antibody
glycoprotein
phylogenetic tree
title Analysis of cross neutralizing activity of antibodies from sera of severe fever with thrombocytopenia syndrome patients to deal with different genotype strains
title_full Analysis of cross neutralizing activity of antibodies from sera of severe fever with thrombocytopenia syndrome patients to deal with different genotype strains
title_fullStr Analysis of cross neutralizing activity of antibodies from sera of severe fever with thrombocytopenia syndrome patients to deal with different genotype strains
title_full_unstemmed Analysis of cross neutralizing activity of antibodies from sera of severe fever with thrombocytopenia syndrome patients to deal with different genotype strains
title_short Analysis of cross neutralizing activity of antibodies from sera of severe fever with thrombocytopenia syndrome patients to deal with different genotype strains
title_sort analysis of cross neutralizing activity of antibodies from sera of severe fever with thrombocytopenia syndrome patients to deal with different genotype strains
topic severe fever with thrombocytopenia syndrome bunyavirus
humoral immunity
neutralizing antibody
glycoprotein
phylogenetic tree
url https://www.frontiersin.org/articles/10.3389/fmicb.2022.1020545/full
work_keys_str_mv AT jiaxinxu analysisofcrossneutralizingactivityofantibodiesfromseraofseverefeverwiththrombocytopeniasyndromepatientstodealwithdifferentgenotypestrains
AT yuanniliu analysisofcrossneutralizingactivityofantibodiesfromseraofseverefeverwiththrombocytopeniasyndromepatientstodealwithdifferentgenotypestrains
AT fanzhang analysisofcrossneutralizingactivityofantibodiesfromseraofseverefeverwiththrombocytopeniasyndromepatientstodealwithdifferentgenotypestrains
AT xinwang analysisofcrossneutralizingactivityofantibodiesfromseraofseverefeverwiththrombocytopeniasyndromepatientstodealwithdifferentgenotypestrains
AT weijinhuang analysisofcrossneutralizingactivityofantibodiesfromseraofseverefeverwiththrombocytopeniasyndromepatientstodealwithdifferentgenotypestrains
AT yulongwu analysisofcrossneutralizingactivityofantibodiesfromseraofseverefeverwiththrombocytopeniasyndromepatientstodealwithdifferentgenotypestrains
AT boqingli analysisofcrossneutralizingactivityofantibodiesfromseraofseverefeverwiththrombocytopeniasyndromepatientstodealwithdifferentgenotypestrains
AT jiapengzhuang analysisofcrossneutralizingactivityofantibodiesfromseraofseverefeverwiththrombocytopeniasyndromepatientstodealwithdifferentgenotypestrains
AT yixingbing analysisofcrossneutralizingactivityofantibodiesfromseraofseverefeverwiththrombocytopeniasyndromepatientstodealwithdifferentgenotypestrains
AT youchunwang analysisofcrossneutralizingactivityofantibodiesfromseraofseverefeverwiththrombocytopeniasyndromepatientstodealwithdifferentgenotypestrains
AT yuanyuanqiao analysisofcrossneutralizingactivityofantibodiesfromseraofseverefeverwiththrombocytopeniasyndromepatientstodealwithdifferentgenotypestrains